Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa

Digestive Diseases and Sciences

Volumn 45, Issue 3, 2000, Pages 606-613

  Ichikawa, Takafumi ^a,b   Ishihara, Kazuhiko ^a   Hayashida, Hiroaki ^a   Hiruma, Hiromi ^a   Saigenji, Katsunori ^a   Hotta, Kyoko ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antrum; Ecabet sodium; Gastric mucin biosynthesis; Monoclonal antibody; Prostaglandin E2; Rat

Indexed keywords

12 SULFODEHYDROABIETIC ACID; ANTIULCER AGENT; MUCIN; PROSTAGLANDIN E2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; STOMACH MUCOSA;

ANIMALS; ANTI-ULCER AGENTS; DINOPROSTONE; DITERPENES; DITERPENES, ABIETANE; GASTRIC MUCOSA; GLUCOSAMINE; IMMUNOHISTOCHEMISTRY; MALE; MUCINS; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; STIMULATION, CHEMICAL;

EID: 0034026848     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005469913079     Document Type: Article

References (39)

1. 1. Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77:433-443, 1979
2. 2. Robert A, Nezamis JE, Lancaster C, Davis JP, Field SO, Hanchar AJ: Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated hy prostaglandins. Am J Physiol 245:G113-G121, 1983
3. 3. Bayerdorffer E, Lehn N, Hatz R, Mannes GA, Oertel H, Sauerbruch T, Stolte M: Difference in expression of Helicobacler pylori gastritis in antrum and body. Gastroenterology 102:1575-1582, 1992
4. 4. Satoh K, Kimura K, Yoshida Y, Kasano T, Kihira K, Taniguchi Y: A topographical relationship between Helicobaeter pylori and gastritis: quantitative assessment of Helicobacter pylori in the gastric mucosa. Am J Gastroenterol 86:285-291, 1991
5. 5. Allen A, Hutton DA, Leonard AJ, Pearson JP, Sellers LA: The role of mucus in the protection of the gastroduodenal mucosa. Scand J Gastroenterol 21(suppl 125):71-78, 1986
6. 6. Piotrowski J, Slomiany A, Murty VL, Fekete Z, Slomiany BL: Inhibition of Helicobacter pylori colonization by sulfated gastric mucin. Biochem Int 24:749-756, 1991
7. 7. Tzouvelekis LS, Mentis AF, Makris AM, Spiliadis C, Blackwell C, Weir DM: In vitro binding of Helicobacter pylori to human gastric mucin. Infect Immun 59:4252-4254, 1991
8. 8. Ohara S, Ishihara K, Hotta K: Two types of rat gastric mucus glycoprotein subunits. J Biochem 103:1050-1053, 1988
9. 9. Goso Y, Hotta K: Types of oligosaccharide sulphation, depending on mucus glycoprotein source, corpus or antral, in rat stomach. Biochem J 264:805-812, 1989
10. 10. Ichikawa T, Ishihara K, Saigenji K, Hotta K: Effects of acid-inhibitory antiulcer drugs on mucin biosynthesis in the rat stomach. Eur J Pharmacol 251:107-111, 1994
11. 11. Ichikawa T, Ishihara K, Shibata M, Yamaura T, Saigenji K, Hotta K: Stimulation of mucin biosynthesis in rat gastric mucosa by FRG-8813 and its structural analogs. Eur J Pharmacol 297:87-92, 1996
12. 12. Ichikawa T, Ishihara K, Saigenji K, Hotta K: Structural requirements for roxatidine in the stimulant effect of rat gastric mucin synthesis and the participation of nitric oxide in this mechanism. Br J Pharmacol 122:1230-1236, 1997
13. 13. Onoda Y, Magaribuchi T, Tamaki H: Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric secretion and experimental ulcers in rats. Jpn J Pharmacol 51:65-73, 1989
14. 14. Onoda Y, Takido M, Magaribuchi T, Tamaki H: Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced hy necrotizing agents and gastric mucosal defensive factors in rats. Jpn J Pharmacol 52:631-638, 1990
15. 15. Ishihara K, Kurihara M, Goso Y, Ota H, Katsuyama T, Hotta K: Establishment of monoclonal antibodies against carbohydrate moiety of gastric mucins distributed in the different sites and layers of rat gastric mucosa. Glycoconjugate J 13:857-864, 1996
16. 16. Gono Y, Kusakabe T, Ichikawa T, Ishihara K, Hotta K, Kawakami T, Takenaka T, Sakai F: Regional differences in the distribution of gastrin-, somatostatin-, and serotonin-immunoreactive basal granulated cells in the rat stomach: A quantitative analysis using antibodies against protein gene product 9.5 and gastric mucins. Biomedical Res 19:101-109, 1998
17. 17. Ichikawa T, Ishihara K, Saigenji K, Hotta K: Stimulation of mucus glycoprotein biosynthesis in rat gastric mucosa by gastrin. Biochem Pharmacol 46:1551-1557, 1993
18. 18. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85, 1985
19. 19. Boughton-Smith NK, Whittle BJR: Stimulation and inhibition of prostacyclin formation in the gastric mucosa and ileum in vitro by anti-inflammatory agents. Br J Pharmacol 78:173-180, 1983
20. 20. Kinoshita M, Kume E, Tamaki H: Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium. J Pharmacol Exp Ther 275:494-501, 1995
21. 21. Fazekas de St. Groth S, Scheidegger D: Production of monoclonal antibodies: Strategy and tactics. J Immunol Methods 35(1-2):1-21, 1980
22. 22. Köhler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497, 1975
23. 23. Ishihara K, Kurihara M, Goso Y, Urata T, Ota H, Katsuyama T, Hotta K: Peripheral alpha-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: Epitope recognized by a newly characterized monoclonal antibody. Biochem J 318:409-416, 1996
24. 24. Kinoshita M, Iwasaki H, Yasoshima A, Tamaki H: Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats. Biol Pharm Bull 16:1220-1225, 1993
25. 25. Takeuchi K, Yamakuni H, Nobuhara Y, Okabe S: Functional and morphological alterations in the rat stomach following exposure to hypertonic NaCl solution. Jpn J Pharmacol 42:549-560, 1986
26. 2 on gastric surface epithelial cell damage induced by 20% ethanol in rats. Jpn J Pharmacol 45:327-334, 1987
27. 27. Scheiman JM, Kraus ER, Boland CR: Regulation of canine gastric mucin synthesis and phospholipid secretion by acid secretagogues. Gastroenterology 103:1842-1850, 1992
28. 28. Heim HK, Sewing KF: Pharmacological regulation of gastric mucous glycoprotein secretion. Eur J Gastroenterol Hepatol 7:1105-1122, 1995
29. 29. Ichikawa T, Ishihara K, Kusakabe T, Kurihara M, Kawakami T, Takenaka T, Saigenji K, Hotta K: Distinct effects of tetragastrin, histamine, and CCh on rat gastric mucin synthesis and contribution of NO. Am J Physiol 274:G138-G146, 1998
30. 30. Ishihara K, Kuwata H, Ohara S, Okabe H, Hotta K: Changes of rat gastric mucus glycoproteins in cytoprotection: Influences of prostaglandin derivatives. Digestion 39:162-171, 1988
31. 2+ -dependent and -independent secretagogue action on gastric mucus secretion in rabbit mucosal explants. Am J Physiol 256:G739-G746, 1989
32. 2 in cholinergic-mediated glycoprotein synthesis in canine antrum. Dig Dis Sci 37:1045-1050, 1992
33. 33. Ito Y, Fukushima T, Sugawara Y, Takaiti O, Nakamura S: Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)-1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenccarboxylic acid 6-sodium salt pentahydrate (TA-2711). I. Disposition, metabolism and protein binding in rats and dogs. J Pharmacobio-Dyn 14:533-546, 1991
34. 34. Bayerdorffer E, Oertel H, Lehn N, Kasper G, Mannes GA, Sauerbruch T, Stolte M: Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol 42:834-839, 1989
35. 35. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR: Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2:1437-1442, 1988
36. 36. Labenz J, Borsch G: Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 35:19-22, 1994
37. 37. Ohkusa T, Takashimizu I, Fujiki K, Araki A, Ariake K, Shimoi K, Honda K, Enomoto Y, Sakurazawa T, Horiuchi T, Suzuki S, Ishii K, Ishikura T: Prospective evaluation of a new anti-ulcer agent, ecabet sodium, for the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 12:457-461, 1998
38. 38. Shibata K, Ito Y, Hongo A, Yasoshima A, Endo T, Ohashi M: Bacterial activity of a new antiulcer agent, ecahet sodium, against Helicobacter pylori under acidic conditions. Antimicrob Agents Chemother 39:1295-1299, 1995
39. 39. Slomiany BL, Sarosiek J, Slomiany A: Gastric mucus and the mucosal barrier. Dig Dis 5:125-145, 1987